Even as everyone was going through the Science and Nature reviews of the rejected STAP papers this week, something else on the STAP front that happened last week. What’s up? Well, the STAP Nature papers are retracted, RIKEN CDB is going to be reorganized, RIKEN CDB has tried at least 22 times to make STAP […]
Harvard STAP cell authors release new protocol, affirm belief in phenomenon Read More »
StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought
Interview with StemCells Inc. leadership on hot topics Read More »
What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at the moment in no particular order. You can see a lot of translational/clinical things are on my mind. I’ve
Key questions for stem cell field bouncing around on a Friday morning Read More »
Type 1 Diabetes is a huge global problem. Where are the solutions that would compliment or replace insulin therapy for diabetics? There haven’t been too many that have gotten very far, which makes the news of a potential stem cell-based therapy moving along in the pipeline all the more exciting. ViaCyte (see more posts here,
Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product Read More »
Who is trying, via the name BioGatekeeper, Inc., to nullify Yamanaka’s patent on cellular reprogramming to produce induced pluripotent stem (iPS) cells? The readers of this blog never cease to amaze me. What an informed, energetic, bright group. Within just days they may have collectively shed some light on an intriguing mystery in the stem cell field surrounding the
Blog readers investigate BioGatekeeper, the Yamanaka patent challenger Read More »
What the heck happened to the FDA when it comes to regulating stem cell clinics? Has it given up? Or does it just seem that way because it moves in slow motion? The FDA might as well have thrown in the towel because, as I like to say, the stem cell field moves in dog years.
Has the FDA given up on regulating stem cell clinics? Read More »
The deadline for our stem cell video contest is coming up fast and is a week from today on August 13. Please send your entries to me by email. The stem cell videos entries can be of any format and any topic, as long as it relates to stem cells somehow. It could be a
Stem Cell Video Contest with $100 prize: Deadline in 1 week Read More »
Today has been a dark day of mourning for science following the death by suicide of Dr. Yoshiki Sasai. I did not know Dr. Sasai personally, but was very impressed with his work. His suicide leaves me feeling very sad and it seems like an appropriate time for reflection. (update I did a post on suicides by
Reflecting on Sasai tragedy, STAP, & flawed field of science Read More »
Stem cell-based Regenerative Medicine has huge power for good in the clinic and at the same time great potential for economic development. Those two things go hand in hand. As I argued in my stem cell book, biotech commercialization of stem cells is not a bad thing, but rather if it is done responsibly it
Reflecting on Regenerative Medicine As A Brand Read More »
Is there real promise of stem cells for autism? At this point the jury remains out on that question, but a growing number of kids are nonetheless getting such “treatments” at for-profit dubious clinics. Academic clinical researchers are interested in this area as well. Still, the potential use of stem cells to treat autism is
Duke Launches Large, Debated Stem Cells for Autism Trial Read More »